Clinical Scorecard: Dietary Calcium Consumption and Its Relationship with Bone Mineral Density in Individuals with HIV and/or Chronic Hepatitis C
At a Glance
Category
Detail
Condition
Reduced bone mineral density (BMD), osteopenia, and osteoporosis in HIV, HCV, and HIV/HCV coinfected individuals
Key Mechanisms
HIV infection, antiretroviral therapy, HIV-related inflammation, chronic inflammation and liver dysfunction in HCV, and traditional risk factors including nutritional deficiencies such as calcium
Target Population
Men with virologically suppressed HIV, untreated HCV monoinfection, HIV/HCV coinfection, and noninfected controls
Care Setting
Veterans receiving care at VA North Texas Health Care System
Key Highlights
Osteopenia and osteoporosis are prevalent among individuals with HIV, HCV, and HIV/HCV coinfection.
No overall association between infection status and BMD was found in this study population.
Lower dietary calcium intake was correlated with reduced BMD only in patients with HCV monoinfection.
Guideline-Based Recommendations
Diagnosis
Use dual-energy x-ray absorptiometry (DXA) to measure BMD at lumbar spine, femoral neck, and total hip.
Define osteopenia as T score between -1.0 and -2.49 and osteoporosis as T score ≤ -2.5 according to WHO criteria.
Management
Ensure adequate dietary calcium intake to support bone health, especially in patients with HCV monoinfection.
Consider calcium supplementation (assumed 1000 mg/day) if dietary intake is insufficient.
Monitoring & Follow-up
Regular assessment of BMD in patients with HIV, HCV, or coinfection to identify osteopenia or osteoporosis.
Monitor dietary calcium intake using validated tools such as the Hertzler-Frary dietary calcium questionnaire.
Risks
Increased fracture risk associated with reduced BMD in HIV, HCV, and coinfected populations.
Traditional modifiable risk factors include low BMI, tobacco use, alcohol consumption, physical inactivity, hypogonadism, steroid use, and nutritional deficiencies.
Patient & Prescribing Data
Men with virologically suppressed HIV, untreated HCV, HIV/HCV coinfection, and controls
Calcium intake was only significantly correlated with BMD in HCV monoinfected patients with osteoporosis, suggesting targeted nutritional interventions may be beneficial in this subgroup.
Clinical Best Practices
Assess and address modifiable risk factors for reduced BMD including nutritional deficiencies and lifestyle factors.
Use validated dietary assessment tools to evaluate calcium intake in patients at risk for bone loss.
Incorporate BMD screening in routine care for patients with HIV, HCV, or HIV/HCV coinfection.
Tailor calcium supplementation and dietary counseling particularly for HCV monoinfected patients with low BMD.
